{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:37:04Z","timestamp":1783111024978,"version":"3.54.6"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-2140004"],"award-info":[{"award-number":["DGE-2140004"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["OPP1212966\/INV-009313"],"award-info":[{"award-number":["OPP1212966\/INV-009313"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.lanmic.2025.101265","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:08:26Z","timestamp":1768334906000},"page":"101265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4356-6317","authenticated-orcid":false,"given":"Caroline J","family":"Duncombe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna E B","family":"Hergott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weston","family":"Staubus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6215-0183","authenticated-orcid":false,"given":"Mirte","family":"Balke-Buijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G","family":"Kublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick E","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Talley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B Kim Lee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meta","family":"Roestenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-0131","authenticated-orcid":false,"given":"Sean C","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101265_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.lanmic.2025.101265_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0141-9838.2004.00710.x","article-title":"Hormonal and immunological mechanisms mediating sex differences in parasite infection","volume":"26","author":"Klein","year":"2004","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.lanmic.2025.101265_bib3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1572-0241.2000.01525.x","article-title":"Gender distribution in asymptomatic and invasive amebiasis","volume":"95","author":"Acuna-Soto","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lanmic.2025.101265_bib4","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/314999","article-title":"Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression","volume":"180","author":"Mohamed-Ali","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib5","article-title":"Sex difference in the associations among risk factors with hepatitis B and C infections in a large Taiwanese population study","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.lanmic.2025.101265_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00281-012-0345-5","article-title":"The skin: where malaria infection and the host immune response begin","volume":"34","author":"Sinnis","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.lanmic.2025.101265_bib7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/jcm.27.7.1434-1437.1989","article-title":"Evidence for a 6\u00b75-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection","volume":"27","author":"Murphy","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lanmic.2025.101265_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12936-015-0541-6","article-title":"Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies","volume":"14","author":"Hodgson","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101265_bib9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: biology and disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.lanmic.2025.101265_bib10","first-page":"185","article-title":"Sex-linked differences in malaria risk across the lifespan","volume":"441","author":"Briggs","year":"2023","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.lanmic.2025.101265_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4269\/ajtmh.2004.71.2.0700196","article-title":"Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction","volume":"71","author":"Hermsen","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lanmic.2025.101265_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00479-17","article-title":"Controlled human malaria infection: applications, advances, and challenges","volume":"86","author":"Stanisic","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2025.101265_bib13","article-title":"Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial","volume":"9","author":"Em","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101265_bib14","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/infdis\/jiu293","article-title":"Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites","volume":"210","author":"Bijker","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib15","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/cid\/ciz1010","article-title":"Chemoprophylaxis vaccination: phase I study to explore stage-specific immunity to Plasmodium falciparum in US adults","volume":"71","author":"Healy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/jix613","article-title":"A randomized trial evaluating the prophylactic activity of DSM265 against preerythrocytic Plasmodium falciparum infection during controlled human malarial infection by mosquito bites and direct venous inoculation","volume":"217","author":"Murphy","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn9709","article-title":"A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection","volume":"14","author":"Murphy","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2025.101265_bib18","doi-asserted-by":"crossref","first-page":"e2407","DOI":"10.1093\/cid\/ciaa952","article-title":"Safety, pharmacokinetics, and causal prophylactic efficacy of KAF156 in a Plasmodium falciparum human infection study","volume":"73","author":"Kublin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5629","article-title":"A double-blind, placebo-controlled phase 1\/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1","volume":"12","author":"Roestenberg","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2025.101265_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009594","article-title":"PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: a randomized, placebo-controlled trial with controlled human malaria infection","volume":"17","author":"Murphy","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101265_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4269\/ajtmh.2012.10-0658","article-title":"Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials","volume":"86","author":"Murphy","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lanmic.2025.101265_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03347-2","article-title":"Single immunization with genetically attenuated Pf\u0394mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial","volume":"31","author":"Roozen","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.lanmic.2025.101265_bib23","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","article-title":"Safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite","volume":"391","author":"Lamers","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101265_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-021-03684-z","article-title":"Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity","volume":"595","author":"Mwakingwe-Omari","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.lanmic.2025.101265_bib26","series-title":"Parasitic diseases, 7th edition","author":"Despommier","year":"2019"},{"key":"10.1016\/j.lanmic.2025.101265_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12936-015-0817-x","article-title":"Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-na\u00efve volunteers: effect of injection volume and dose on infectivity rates","volume":"14","author":"G\u00f3mez-P\u00e9rez","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101265_bib25","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/infdis\/jiz410","article-title":"Dose-dependent infectivity of aseptic, purified, cryopreserved Plasmodium falciparum 7G8 sporozoites in malaria-naive adults","volume":"220","author":"Laurens","year":"2019","journal-title":"J Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.lanmic.2025.101265_bib29","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/infdis\/jiu063","article-title":"Controlled human malaria infection","volume":"209","author":"Spring","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-127-3-199708010-00010","article-title":"Experimental challenge of volunteers with malaria","volume":"127","author":"Hoffman","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lanmic.2025.101265_bib31","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1038\/s41467-024-49041-2","article-title":"Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms","volume":"15","author":"Ferrer","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2025.101265_bib32","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.vaccine.2024.03.072","article-title":"A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-na\u00efve adults","volume":"42","author":"Cummings","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101265_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004423","article-title":"Phase 1\/2a trial of Plasmodium vivax malaria vaccine candidate VMP001\/AS01B in malaria-naive adults: safety, immunogenicity, and efficacy","volume":"10","author":"Bennett","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12936-016-1435-y","article-title":"Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity","volume":"15","author":"Hickey","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101265_bib35","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4161\/hv.24941","article-title":"Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection","volume":"9","author":"Tamminga","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lanmic.2025.101265_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124243","article-title":"Heterologous protection against malaria after immunization with Plasmodium falciparum sporozoites","volume":"10","author":"Schats","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101265_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59872","article-title":"Sex-based differences in clearance of chronic Plasmodium falciparum infection","volume":"9","author":"Briggs","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.lanmic.2025.101265_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2875-14-7","article-title":"Disparities of Plasmodium falciparum infection, malaria-related morbidity and access to malaria prevention and treatment among school-aged children: a national cross-sectional survey in C\u00f4te d\u2019Ivoire","volume":"14","author":"Houngbedji","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101265_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105189","article-title":"Longitudinal changes in iron homeostasis in human experimental and clinical malaria","volume":"105","author":"Woolley","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lanmic.2025.101265_bib40","first-page":"963","article-title":"Growth rate of Plasmodium falciparum: analysis of parasite growth data from malaria volunteer infection studies","volume":"221","author":"Wockner","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101265_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10571-019-00652-0","article-title":"Brain control of sexually dimorphic liver function and disease: the endocrine connection","volume":"39","author":"Brie","year":"2019","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.lanmic.2025.101265_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107795","article-title":"Sex differences in gene expression and regulatory networks across 29 human tissues","volume":"31","author":"Lopes-Ramos","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.lanmic.2025.101265_bib43","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1210\/me.2006-0007","article-title":"Growth hormone regulation of sex-dependent liver gene expression","volume":"20","author":"Waxman","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.lanmic.2025.101265_bib44","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/cells12121604","article-title":"The influence of sex hormones in liver function and disease","volume":"12","author":"Kasarinaite","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.lanmic.2025.101265_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1006716","article-title":"Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ vaccine does not translate into increased protective efficacy","volume":"13","author":"Kc","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanmic.2025.101265_bib46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4269\/ajtmh.18-0476","article-title":"The controlled human malaria infection experience at the University of Maryland","volume":"100","author":"Friedman-Klabanoff","year":"2019","journal-title":"Am J Trop Med Hyg"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:20:43Z","timestamp":1771507243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666524725001934"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101265","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101265"}}